US EditionThousands Who Could Benefit From Mounjaro 'Missing Out on NHS Care' - Liverpool Echo
Only 18 of 42 NHS Integrated Care Boards have begun prescribing Mounjaro, with funding covering just 10% of eligible patients, causing inequity in access to obesity treatment.
- On September 2, 2025, BMJ data show thousands miss out on Mounjaro because fewer than half of Integrated Care Boards across England have started prescribing it due to funding gaps.
- The phased rollout over up to 12 years was adopted because GPs could be overwhelmed, yet initial funding covers only about 10% of NHS England's first-year demand for 220,000 patients.
- BMJ figures show that only nine ICBs have funding for at least 70% of eligible patients, while four ICBs cover 25% or less with Coventry and Warwickshire worst, and the single ICB reported funding for just 376 patients despite higher eligibility.
- Many patients currently pay privately for Mounjaro and Eli Lilly's August price rise of up to 170% has priced some out, while Health Secretary Wes Streeting pledged to prevent this.
- NHS England estimates around three million patients may be eligible, while five ICBs consider tighter criteria as NHS modelling warns treatment could account for 18% of GP appointments, straining capacity.
Insights by Ground AI
Does this summary seem wrong?
21 Articles
21 Articles
Telegraph & Argus+17 Reposted by 17 other sources
Thousands of patients 'missing out' on NHS Mounjaro due to postcode lottery
Fewer than half of commissioning bodies across England have even started prescribing the drug on the NHS, despite health service guidance
·Bradford, United Kingdom
Read Full Article
perspectivemedia.comReposted by 
Belfast Telegraph
Belfast TelegraphThousands of people who could benefit from Mounjaro ‘missing out on NHS care’
The vast majority of patients on the weight loss jab currently pay for it privately. Thousands of people who could benefit from the weight loss jab Mounjaro on the NHS are missing out due to funding issues, figures suggest. Fewer than half (18 out of 42) of commissioning bodies across England have started prescribing the drug on the NHS in line with health service guidance, according to data gathered by the British Medical Journal (BMJ). NHS Eng…
Coverage Details
Total News Sources21
Leaning Left1Leaning Right0Center17Last UpdatedBias Distribution94% Center
Bias Distribution
- 94% of the sources are Center
94% Center
C 94%
Factuality
To view factuality data please Upgrade to Premium
